MTCO1P19

Across TCGA pan-cancer cohorts, MTCO1P19 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated MTCO1P19 data layer.

The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher MTCO1P19 RNA is associated with better overall survival. In most high-consensus cancer types, elevated MTCO1P19 expression acts as an unfavorable survival marker, although some lineages such as BLCA and LUAD show a favorable association.

BLCA, KIRC, and CHOL are the cancer types where MTCO1P19 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BLCA	OS	Tertile	III,IV	0.686	0.493	<.001	101	view →
KIRC	OS	Tertile	All	0.530	0.666	.004	54	view →
CHOL	OS	Tertile	III,IV	0.024	0.772	.008	54	view →
LUAD	OS	Tertile	II,III,IV	0.663	0.390	.010	51	view →
LAML	DFS	Median	All	0.545	0.375	.007	24	view →
LGG	OS	Tertile	All	0.310	0.487	.006	21	view →
UCS	DFS	Tertile	All	0.176	0.493	.010	18	view →
SKCM	DFS	Tertile	III,IV	0.475	0.225	.023	18	view →
OV	OS	Tertile	III,IV	0.730	0.655	.037	16	view →
KICH	DFS	Quartile	II,III,IV	0.554	0.899	.027	10	view →
ACC	DFS	Tertile	III,IV	0.226	0.700	<.001	9	view →
HNSC	DFS	Tertile	All	0.798	0.682	.038	9	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

MTCO1P19–BLCA (OS)

Open the BLCA breakdown →